CM
TEVA icon

Caption Management’s Teva Pharmaceuticals TEVA Stock Holding History

Caption Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.8M Buy
1,089,500
+920,000
+543% +$29.6M 0.19% 109
2025
Q4 		$5.29M Buy
169,500
+89,500
+112% +$2.2M 0.04% 503
2025
Q3 		$1.62M Buy
+80,000
New +$1.41M 0.01% 926
2025
Q2 		– Sell
-363,300
Closed -$5.58M – 1885
2025
Q1 		$5.58M Sell
363,300
-141,700
-28% -$2.53M 0.05% 362
2024
Q4 		$11.1M Sell
505,000
-45,000
-8% -$819K 0.11% 169
2024
Q3 		$9.91M Sell
550,000
-75,000
-12% -$1.31M 0.16% 154
2024
Q2 		$10.2M Buy
625,000
+541,300
+647% +$8.34M 0.16% 139
2024
Q1 		$1.18M Buy
+83,700
New +$1.06M 0.02% 686
2023
Q4 		– Sell
-27,800
Closed -$284K – 1669
2023
Q3 		$284K Buy
+27,800
New +$259K ﹤0.01% 1047
2023
Q1 		– Sell
-2,359,200
Closed -$21.5M – 1542
2022
Q4 		$21.5M Buy
2,359,200
+674,200
+40% +$5.88M 0.34% 58
2022
Q3 		$13.6M Hold
1,685,000
– – 0.19% 110
2022
Q2 		$12.7M Hold
1,685,000
– – 0.17% 138
2022
Q1 		$15.8M Hold
1,685,000
– – 0.19% 118
2021
Q4 		$13.5M Buy
+1,685,000
New +$15.2M 0.15% 167
2021
Q1 		– Sell
-50,000
Closed -$482K – 1388
2020
Q4 		$482K Buy
+50,000
New +$479K 0.01% 745
2019
Q2 		– Sell
-25,000
Closed -$391K – 823
2019
Q1 		$391K Sell
25,000
-252,200
-91% -$4.45M 0.02% 453
2018
Q4 		$4.27M Sell
277,200
-75,000
-21% -$1.54M 0.34% 95
2018
Q3 		$7.58M Buy
+352,200
New +$8.18M 0.42% 61
2018
Q1 		– Sell
-329,800
Closed -$6.25M – 322
2017
Q4 		$6.25M Buy
+329,800
New +$4.96M 0.65% 50

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caption Management's TEVA Position: Q1 2026 in Review

Caption Management increased its Teva Pharmaceuticals (TEVA) stake by 331% in Q1 2026, buying an estimated $6.92M and bringing the position to 280,058 shares worth $8.44M. The position accounts for 0.05% of the portfolio, ranked #376.

Caption Management first reported a position in TEVA in Q4 2018 and has held it in 15 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Caption Management held 280,058 shares of Teva Pharmaceuticals worth $8.44M as of Q1 2026.
  • Caption Management bought 215,058 Teva Pharmaceuticals shares in Q1 2026, an estimated $6.92M.
  • Teva Pharmaceuticals made up 0.05% of Caption Management's portfolio in Q1 2026, its #376 holding.
  • Caption Management first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 15 quarters since.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.